Iridoid Derivatives as Anticancer Agents: An Updated Review from 1970–2022

Iridoid Derivatives as Anticancer Agents: An Updated Review from 1970–2022

The rise of cancer cases has coincided with the urgent need for the development of potent chemical entities and/or modification of existing commodities to improve their efficacy. Increasing evidence suggests that cancer remains one of the leading causes of death globally, with colon cancer cases alo...

Full description

Bibliographic Details
Main Authors: Tanaka Ndongwe, Bwalya A. Witika, Nontobeko P. Mncwangi, Madan S. Poka, Phumzile P. Skosana, Patrick H. Demana, Beverley Summers, Xavier Siwe-Noundou
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
iridoid derivatives
chemotherapy
cancer agents
isolation
characterization
structure-activity relationship
Online Access:https://www.mdpi.com/2072-6694/15/3/770

Internet

https://www.mdpi.com/2072-6694/15/3/770

Similar Items